Healthcare >> CEO Interviews >> February 24, 1999
DAVID CHISWELL is Chief Executive Officer of Cambridge Antibody
Technology Group. Mr. Chiswell was a founder of CAT and was appointed as
a director in December 1995. He has been responsible for operational
management since the foundation. Previously, he spent nine years at
Amersham International, plc where he held a number of posts, combining
responsibilities for product development and research management. Prior
to moving into the commercial sector in 1981, he gained research
experience in the field of molecular retrovirology at the MRC Institute
of Virology in Glasgow, the department of Immunology and Microbiology at
UCLA in California and in the department of Tumour Virology at the
Imperial Cancer Research Fund in London. Profile
history, your activities, those kinds of things?
Dr. Chiswell: We were established in January, 1990. Since then
